MEDICAL REGULATIONS 11 Edition - FIVB
MEDICAL REGULATIONS 11 Edition - FIVB
MEDICAL REGULATIONS 11 Edition - FIVB
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>FIVB</strong> Medical Regulations – <strong>11</strong>th <strong>Edition</strong><br />
evaluate such request in accordance with the International Standard for<br />
Therapeutic Use Exemptions and render a decision on such request,<br />
which shall be the final decision of the <strong>FIVB</strong>.<br />
4.4.5 WADA, at the request of an Athlete or on its own initiation, may<br />
review the granting or denial of any TUE by the <strong>FIVB</strong>. If WADA<br />
determines that the granting or denial of a TUE did not comply with the<br />
International Standard for Therapeutic Use Exemptions in force at the<br />
time then WADA may reverse that decision. Decisions on TUEs are<br />
subject to further appeal as provided in Article 12.<br />
ARTICLE 5<br />
ANTI-DOPING CONTROLS<br />
5.1 Authority to Test<br />
All Athletes under the jurisdiction of a National Federation shall be subject to In-<br />
Competition Testing by the <strong>FIVB</strong>, the Athlete's National Federation, and any other<br />
Anti-Doping Organization responsible for Testing at a Competition or Event in<br />
which they participate. All Athletes under the jurisdiction of a National Federation,<br />
including Athletes serving a period of ineligibility or a Provisional Suspension,<br />
shall also be subject to Out-of-Competition Testing at any time or place, with or<br />
without advance notice, by the <strong>FIVB</strong>, WADA, the Athlete's National Federation,<br />
the Athlete’s National Anti-Doping Organization, the IOC during the Olympic<br />
Games, and the IPC during Paralympics Games. Target Testing will be made a<br />
priority. Such controls may be carried out during non-<strong>FIVB</strong> world competition (as<br />
friendly tournaments or regional competition). The <strong>FIVB</strong> requires that all its<br />
affiliated National Federations and Confederations organize systematic out-ofcompetition<br />
testing on the players placed under their jurisdiction, in particular<br />
during the training periods before important competitions.<br />
5.2 Responsibility for <strong>FIVB</strong> Testing<br />
The <strong>FIVB</strong> Medical Commission shall be responsible for overseeing all Testing<br />
conducted by drawing up a test distribution plan for the sport of volleyball and<br />
beach volleyball in accordance with Article 4 of the International Standard for<br />
Testing, and for the implementation of that plan, including overseeing all Testing<br />
conducted by or on behalf of the <strong>FIVB</strong>. Testing may be conducted by members of<br />
the <strong>FIVB</strong> Medical Commission or by other qualified persons so authorized by the<br />
<strong>FIVB</strong>.<br />
5.2.1 Anti-doping controls may be performed during any or all<br />
competitions governed by the <strong>FIVB</strong> General Regulations for<br />
International Volleyball and Beach Volleyball Competitions. Such<br />
controls maybe carried out at any stage, following any match of those<br />
competitions, as shall be decided by the <strong>FIVB</strong>.<br />
5.2.2 The minimum number of controls to be performed shall be<br />
determined in the Specific Competition Regulations according to the<br />
decision of the <strong>FIVB</strong> Board of Administration, upon recommendation of<br />
the <strong>FIVB</strong> Medical Commission President. Additional controls can be<br />
performed at other times, either at the request of the <strong>FIVB</strong>, or the<br />
Control Committee.<br />
- 9 -